Total Payments
$274,333
2024 Payments
$48,369
Companies
21
Transactions
782
Medicare Patients
1,386
Medicare Billing
$162,705
Payment Breakdown by Category
Other$204,837 (74.7%)
Consulting$25,286 (9.2%)
Travel$25,189 (9.2%)
Food & Beverage$18,877 (6.9%)
Education$143.43 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $202,237 | 160 | 73.7% |
| Consulting Fee | $25,286 | 16 | 9.2% |
| Travel and Lodging | $25,189 | 165 | 9.2% |
| Food and Beverage | $18,877 | 434 | 6.9% |
| Compensation for serving as faculty or as a speaker for a medical education program | $2,600 | 1 | 0.9% |
| Education | $143.43 | 6 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Teva Pharmaceuticals USA, Inc. | $108,348 | 233 | $0 (2024) |
| ACADIA Pharmaceuticals Inc | $61,275 | 152 | $0 (2024) |
| ABBVIE INC. | $54,877 | 206 | $0 (2024) |
| Axsome Therapeutics, Inc. | $21,134 | 37 | $0 (2024) |
| Avanir Pharmaceuticals, Inc. | $15,814 | 37 | $0 (2022) |
| Otsuka America Pharmaceutical, Inc. | $7,612 | 52 | $0 (2023) |
| IDORSIA PHARMACEUTICALS US INC | $4,178 | 9 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $244.61 | 9 | $0 (2024) |
| Lundbeck LLC | $231.22 | 12 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $116.05 | 7 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $48,369 | 115 | Teva Pharmaceuticals USA, Inc. ($26,481) |
| 2023 | $96,954 | 280 | Teva Pharmaceuticals USA, Inc. ($32,052) |
| 2022 | $64,533 | 186 | Teva Pharmaceuticals USA, Inc. ($32,412) |
| 2021 | $64,477 | 201 | ACADIA Pharmaceuticals Inc ($19,120) |
All Payment Transactions
782 individual payment records from CMS Open Payments — Page 1 of 32
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,400.00 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 12/03/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Travel and Lodging | In-kind items and services | $89.53 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 12/03/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Travel and Lodging | In-kind items and services | $22.78 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 12/03/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Travel and Lodging | In-kind items and services | $14.74 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 11/22/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $8.03 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 11/22/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $7.43 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 11/22/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $2.01 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 11/22/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $1.24 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 11/22/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $0.31 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 11/20/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $121.70 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 11/12/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,800.00 | General |
| Category: Central Nervous System | ||||||
| 11/12/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Travel and Lodging | Cash or cash equivalent | $263.59 | General |
| Category: Central Nervous System | ||||||
| 11/12/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $121.17 | General |
| Category: Central Nervous System | ||||||
| 10/17/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Consulting Fee | Cash or cash equivalent | $1,463.00 | General |
| Category: Psychology/Psychiatric | ||||||
| 10/17/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Travel and Lodging | Cash or cash equivalent | $152.46 | General |
| Category: Psychology/Psychiatric | ||||||
| 10/17/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $119.97 | General |
| Category: Psychology/Psychiatric | ||||||
| 10/16/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.27 | General |
| Category: NEUROSCIENCE | ||||||
| 10/02/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $10.07 | General |
| Category: NEUROSCIENCE | ||||||
| 09/24/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,800.00 | General |
| Category: Central Nervous System | ||||||
| 09/24/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Travel and Lodging | Cash or cash equivalent | $246.34 | General |
| Category: Central Nervous System | ||||||
| 09/24/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $123.97 | General |
| Category: Central Nervous System | ||||||
| 09/11/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $33.40 | General |
| Category: NEUROSCIENCE | ||||||
| 09/10/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $22.03 | General |
| Category: Neuropsychiatry | ||||||
| 08/21/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $13.59 | General |
| Category: NEUROSCIENCE | ||||||
| 08/20/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $24.81 | General |
| Category: Psychology/Psychiatric | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 275 | 510 | $88,676 | $33,337 |
| 2022 | 10 | 336 | 677 | $131,121 | $46,902 |
| 2021 | 11 | 316 | 645 | $109,176 | $39,665 |
| 2020 | 13 | 459 | 819 | $123,063 | $42,801 |
Total Patients
1,386
Total Services
2,651
Medicare Billing
$162,705
Procedure Codes
48
All Medicare Procedures & Services
48 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 36 | 116 | $20,880 | $8,425 | 40.4% |
| 90836 | Psychotherapy with evaluation and management visit, 45 minutes | Office | 2023 | 34 | 86 | $15,050 | $4,690 | 31.2% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Office | 2023 | 37 | 72 | $11,338 | $4,474 | 39.5% |
| 99306 | Initial nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Office | 2023 | 37 | 37 | $10,730 | $4,394 | 40.9% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Office | 2023 | 41 | 80 | $9,600 | $3,854 | 40.2% |
| 99310 | Subsequent nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Office | 2023 | 21 | 34 | $7,990 | $3,384 | 42.4% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2023 | 35 | 45 | $5,400 | $1,952 | 36.1% |
| 99349 | Residence visit for established patient with moderate level of medical decision making, per day, if using time, at least 40 minutes | Office | 2023 | 21 | 24 | $5,352 | $1,467 | 27.4% |
| 99348 | Residence visit for established patient with low level of medical decision making, per day, if using time, at least 30 minutes | Office | 2023 | 13 | 16 | $2,336 | $696.78 | 29.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 44 | 141 | $24,967 | $10,141 | 40.6% |
| 99309 | Follow-up nursing facility visit per day, typically 25 minutes | Facility | 2022 | 52 | 117 | $18,486 | $6,565 | 35.5% |
| 99336 | Established patient custodial care facility, group care, or assisted living visit, typically 40 minutes | Office | 2022 | 34 | 71 | $16,685 | $5,793 | 34.7% |
| 99310 | Follow-up nursing facility visit per day, typically 35 minutes | Facility | 2022 | 43 | 68 | $15,980 | $5,781 | 36.2% |
| 99337 | Established patient custodial care facility, group care, or assisted living visit, typically 1 hour | Office | 2022 | 25 | 48 | $16,128 | $5,629 | 34.9% |
| 90836 | Psychotherapy with evaluation and management visit, 45 minutes | Office | 2022 | 38 | 97 | $16,975 | $5,378 | 31.7% |
| 99306 | Initial nursing facility visit per day, typically 45 minutes | Facility | 2022 | 22 | 22 | $6,380 | $2,366 | 37.1% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2022 | 29 | 45 | $5,400 | $1,940 | 35.9% |
| 99335 | Established patient custodial care facility, group care, or assisted living visit, typically 25 minutes | Office | 2022 | 19 | 29 | $4,756 | $1,372 | 28.8% |
| 99309 | Follow-up nursing facility visit per day, typically 25 minutes | Office | 2022 | 16 | 18 | $2,844 | $1,047 | 36.8% |
| 99308 | Follow-up nursing facility visit per day, typically 15 minutes | Facility | 2022 | 14 | 21 | $2,520 | $889.95 | 35.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 53 | 176 | $30,448 | $12,056 | 39.6% |
| 90836 | Psychotherapy with evaluation and management visit, 45 minutes | Office | 2021 | 49 | 130 | $22,750 | $7,121 | 31.3% |
| 99309 | Subsequent nursing facility visit, typically 25 minutes per day | Facility | 2021 | 41 | 73 | $11,534 | $4,259 | 36.9% |
| 99310 | Subsequent nursing facility visit, typically 35 minutes per day | Facility | 2021 | 25 | 43 | $10,105 | $3,797 | 37.6% |
| 99306 | Initial nursing facility visit, typically 45 minutes per day | Facility | 2021 | 23 | 23 | $6,670 | $2,515 | 37.7% |
About Jennifer Sampang, PH.D, MSN
Jennifer Sampang, PH.D, MSN is a Nurse Practitioner healthcare provider based in Crestview Hills, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/26/2005. The National Provider Identifier (NPI) number assigned to this provider is 1396745899.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Jennifer Sampang, PH.D, MSN has received a total of $274,333 in payments from pharmaceutical and medical device companies, with $48,369 received in 2024. These payments were reported across 782 transactions from 21 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($202,237).
As a Medicare-enrolled provider, Sampang has provided services to 1,386 Medicare beneficiaries, totaling 2,651 services with total Medicare billing of $162,705. Data is available for 4 years (2020–2023), covering 48 distinct procedure/service records.
Ad
Practice Information
- Specialty Nurse Practitioner
- Other Specialties Psychiatric/Mental Health, Registered Nurse
- Location Crestview Hills, KY
- Active Since 07/26/2005
- Last Updated 07/13/2023
- Taxonomy Code 363L00000X
- Entity Type Individual
- NPI Number 1396745899
Products in Payments
- NUPLAZID (Drug) $61,275
- AUSTEDO (Drug) $61,106
- VRAYLAR (Drug) $54,896
- Austedo XR (Drug) $37,184
- Auvelity (Drug) $21,114
- NUEDEXTA (Drug) $17,225
- UZEDY (Drug) $8,314
- QUVIVIQ (Drug) $4,178
- REXULTI (Drug) $3,160
- Nuedexta (Drug) $2,592
- ABILIFY MAINTENA (Drug) $544.10
- SPRAVATO (Drug) $196.08
- LATUDA (Drug) $116.05
- ARISTADA (Drug) $97.04
- TRINTELLIX (Drug) $89.56
- INGREZZA (Drug) $53.02
- Dayvigo (Drug) $52.89
- CAPLYTA (Drug) $52.27
- INVEGA SUSTENNA (Drug) $48.53
- BRINTELLIX (Drug) $46.32
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nurse Practitioner Doctors in Crestview Hills
Molly Lutz, Aprn, Msn, Pmhnp-Bc, APRN, MSN, PMHNP-BC
Nurse Practitioner — Payments: $59,733
Nurse Practitioner $59,733
Sithandiwe Mamutse, Aprn, Msn, Pmhnp-Bc, APRN, MSN, PMHNP-BC
Nurse Practitioner — Payments: $10,067
Nurse Practitioner $10,067
Christina Wolf, Aprn, APRN
Nurse Practitioner — Payments: $9,594
Nurse Practitioner $9,594
Amerika Hull, Aprn, Msn, Pmhnp-Bc, APRN, MSN, PMHNP-BC
Nurse Practitioner — Payments: $7,196
Nurse Practitioner $7,196
Mr. Enis Rosic, Aprn, Agac, APRN, AGAC
Nurse Practitioner — Payments: $5,896
Nurse Practitioner $5,896
Mrs. Cathy Kreimer, Aprn, APRN
Nurse Practitioner — Payments: $4,947
Nurse Practitioner $4,947